Unlocking the potential of antibody drug conjugates : compar

How have advancements in antibody-drug conjugates expanded treatment options for different types of cancer?
The design of ADCs has advanced considerably since initial efforts in the 1980's, when...

Related Keywords

Milano , Lombardia , Italy , Colombo , Western , Sri Lanka , Paul Moore , University Of Glasgow , University Of Alberta , Zymeworks Inc , Russell Publishing , Therapeutic Development , Chief Scientific Officer , Associate Director , Medicinal Chemistry , Senior Director , Russell Publishing Limited , Markets ,